How publishers can fight misinformation in and about science and medicine - Nature Medicine

  • 📰 NatureMedicine
  • ⏱ Reading Time:
  • 20 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 53%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Scientific and medical publishers have a major role in developing guidelines and policies to combat misinformation and disinformation. Comment from Carl Bergstrom and jevinwest uw_ischool UW

The fight against misinformation and disinformation requires the use of every point of leverage available to the scientific and medical communities. Authors need to counter rather than contribute to misinformation. Scientists must challenge questionable results.

Newspapers and magazines must improve practices around health and science reporting. Press offices should dial back the hype. Members of the public need to receive adequate education to identify reliable evidence. In addition, scientific and medical publishers need to take an active role in tackling misinformation by countering the incentives that drive its creation and spread (Box

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 451. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Using gut microorganisms to treat cancer - Nature MedicineStrategies to monitor and modulate gut microorganisms to improve immunity and responses to cancer immunotherapy are increasingly available, with opportunities to expand and iterate on these approaches to treat, intercept and prevent cancer (and other diseases) altogether.
Source: NatureMedicine - 🏆 451. / 53 Read more »

AI drug discoveries to cut costs and save lives: Medicine’s next big thing?It takes millions, if not billions, of dollars to take a drug from the lab to the pharmacy. Last year out of thousands of drugs in clinical trials, the FDA approved 37, the fewest to pass regulatory scrutiny since 2016.
Source: wjxt4 - 🏆 246. / 63 Read more »